Aceto has announced the acquisition of Syntor Fine Chemicals to boost business in differentiated specialty materials and solutions in life sciences and advanced technology end markets. Syntor is an asset-light manufacturer of fine chemicals for pharmaceutical and other life sciences end markets.
Creating Cross-selling Opportunities for Supply Partners
The acquisition of Syntor represents significant progress in New Mountain’s strategic plan for Aceto, as the company continues its track record of growth both organically and through acquisition. The partnership creates significant cross-sell opportunities that benefit customers and supply partners to both businesses.
“
The acquisition of Syntor is an important step in Aceto’s strategic growth plan,” said Gilles Cottier, chief executive officer of Aceto. “
Syntor’s synthesis and formulation capabilities enhance Aceto’s existing services and expand our value-added offerings in life sciences materials. With the addition of Syntor’s technical team, we can provide greater product customization in addition to supplying our current offering of high quality, specialty materials” added Cottier.
Sourcing and Developing Complex Chemistries for Customers
Syntor brings a portfolio of exciting, proprietary products, developed in-house for many blue-chip customers in the life sciences, pharmaceutical, agrochemical, aroma and electronics industries. Syntor’s product leadership will accelerate Syntor leverages Aceto’s global partnerships with customers and suppliers.
“
We are very pleased and excited about our partnership with Aceto,” said Simon Knowles, managing partner of Syntor. “
The two companies are well aligned in their culture and drive to maximize value to customers through sourcing and development of complex chemistries. We believe Syntor will thrive with the support of Aceto’s global infrastructure and we look forward to contributing to the next stage of growth for the combined company” added Knowles.
Source: Aceto